Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05968326 |
|---|---|
| Brief Title: | A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected Pancreatic Ductal Adenocarcinoma (IMCODE003) |
| First Submitted : | July 21, 2023 |
| First Submitted that Met QC Criteria : | July 21, 2023 |
| First Posted : | August 1, 2023 |
| Last Update Submitted that Met QC Criteria : | April 25, 2024 |
| Last Update Posted : | April 26, 2024 |